Carbon monoxide releasing molecule-2 CORM-2 represses global protein synthesis by inhibition of eukaryotic elongation factor eEF2.

[1]  M. Zou,et al.  AMP-activated protein kinase, stress responses and cardiovascular diseases. , 2012, Clinical science.

[2]  D. Sabatini,et al.  A unifying model for mTORC1-mediated regulation of mRNA translation , 2012, Nature.

[3]  E. Denamur,et al.  Differential antibacterial activity against Pseudomonas aeruginosa by carbon monoxide-releasing molecules. , 2012, Antioxidants & redox signaling.

[4]  T. Loop,et al.  p38β-regulated induction of the heat shock response by carbon monoxide releasing molecule CORM-2 mediates cytoprotection in lung cells in vitro. , 2011, European journal of pharmacology.

[5]  S. Gamblin,et al.  AMP-activated protein kinase: nature's energy sensor. , 2011, Nature chemical biology.

[6]  M. Teixeira,et al.  Reactive Oxygen Species Mediate Bactericidal Killing Elicited by Carbon Monoxide-releasing Molecules* , 2011, The Journal of Biological Chemistry.

[7]  G. Kaul,et al.  Eukaryotic elongation factor‐2 (eEF2): its regulation and peptide chain elongation , 2011, Cell biochemistry and function.

[8]  M. Mayer,et al.  The Chaperone Network Connected to Human Ribosome-Associated Complex , 2011, Molecular and Cellular Biology.

[9]  L. Otterbein,et al.  The therapeutic potential of carbon monoxide , 2010, Nature Reviews Drug Discovery.

[10]  S. Kimball,et al.  Control of Translation Initiation through Integration of Signals Generated by Hormones, Nutrients, and Exercise* , 2010, The Journal of Biological Chemistry.

[11]  N. Sonenberg,et al.  mTORC1-Mediated Cell Proliferation, But Not Cell Growth, Controlled by the 4E-BPs , 2010, Science.

[12]  M. Humar,et al.  Carbon Monoxide Releasing Molecule-2 Inhibits Pancreatic Stellate Cell Proliferation by Activating p38 Mitogen-Activated Protein Kinase/Heme Oxygenase-1 Signaling , 2010, Molecular Pharmacology.

[13]  T. Yoshikawa,et al.  Carbon Monoxide Liberated from CO-Releasing Molecule (CORM-2) Attenuates Ischemia/Reperfusion (I/R)-Induced Inflammation in the Small Intestine , 2010, Inflammation.

[14]  E. Denamur,et al.  A carbon monoxide‐releasing molecule (CORM‐3) exerts bactericidal activity against Pseudomonas aeruginosa and improves survival in an animal model of bacteraemia , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  M. Humar,et al.  Heme Oxygenase-1 Inhibits the Proliferation of Pancreatic Stellate Cells by Repression of the Extracellular Signal-Regulated Kinase1/2 Pathway , 2008, Journal of Pharmacology and Experimental Therapeutics.

[16]  S. Gordon,et al.  AMPK activation attenuates S6K1, 4E-BP1, and eEF2 signaling responses to high-frequency electrically stimulated skeletal muscle contractions. , 2008, Journal of applied physiology.

[17]  R. Bülow,et al.  Antifibrogenic effects of histone deacetylase inhibitors on pancreatic stellate cells. , 2007, Biochemical pharmacology.

[18]  J. Balschi,et al.  Metformin and phenformin activate AMP-activated protein kinase in the heart by increasing cytosolic AMP concentration. , 2007, American journal of physiology. Heart and circulatory physiology.

[19]  J. Pouysségur,et al.  The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition , 2007, Oncogene.

[20]  T. Billiar,et al.  Carbon monoxide signals via inhibition of cytochrome c oxidase and generation of mitochondrial reactive oxygen species , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  M. Alcaraz,et al.  The carbon monoxide‐releasing molecule CORM‐2 inhibits the inflammatory response induced by cytokines in Caco‐2 cells , 2007, British journal of pharmacology.

[22]  M. Omary,et al.  The pancreatic stellate cell: a star on the rise in pancreatic diseases. , 2007, The Journal of clinical investigation.

[23]  Jason M. Lynam,et al.  Bioactive Properties of Iron-Containing Carbon Monoxide-Releasing Molecules , 2006, Journal of Pharmacology and Experimental Therapeutics.

[24]  Y. Surh,et al.  Carbon monoxide protects PC12 cells from peroxynitrite-induced apoptotic death by preventing the depolarization of mitochondrial transmembrane potential. , 2006, Biochemical and biophysical research communications.

[25]  Jawed Alam,et al.  Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. , 2006, Physiological reviews.

[26]  C. Proud.  Regulation of protein synthesis by insulin. , 2006, Biochemical Society transactions.

[27]  M. Rennie.  Why muscle stops building when it's working , 2005, The Journal of physiology.

[28]  R. Motterlini,et al.  Mitochondrial Respiratory Chain and NAD(P)H Oxidase Are Targets for the Antiproliferative Effect of Carbon Monoxide in Human Airway Smooth Muscle* , 2005, Journal of Biological Chemistry.

[29]  R. Foresti,et al.  Carbon monoxide‐releasing molecules (CO‐RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages , 2005, British journal of pharmacology.

[30]  M. Apte,et al.  Mechanisms of Pancreatic Fibrosis , 2005, Digestive Diseases.

[31]  J S Wilson,et al.  Desmoplastic Reaction in Pancreatic Cancer: Role of Pancreatic Stellate Cells , 2004, Pancreas.

[32]  J. Raymond,et al.  Mitogen-induced Rapid Phosphorylation of Serine 795 of the Retinoblastoma Gene Product in Vascular Smooth Muscle Cells Involves ERK Activation* , 2004, Journal of Biological Chemistry.

[33]  Christopher G. Proud,et al.  A Novel mTOR-Regulated Phosphorylation Site in Elongation Factor 2 Kinase Modulates the Activity of the Kinase and Its Binding to Calmodulin , 2004, Molecular and Cellular Biology.

[34]  P. Alm,et al.  Carbon monoxide stimulates insulin release and propagates Ca2+ signals between pancreatic beta-cells. , 2003, American journal of physiology. Endocrinology and metabolism.

[35]  Ò. Miró,et al.  Carbon monoxide specifically inhibits cytochrome c oxidase of human mitochondrial respiratory chain. , 2003, Pharmacology & toxicology.

[36]  N. Bodyak,et al.  Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury , 2003, Nature Medicine.

[37]  C. Proud,et al.  Regulation of peptide-chain elongation in mammalian cells. , 2002, European journal of biochemistry.

[38]  N. Matsumura,et al.  Establishment of a novel collagenase perfusion method to isolate rat pancreatic stellate cells and investigation of their gene expression of TGF-beta1, type I collagen, and CTGF in primary culture or freshly isolated cells. , 2002, Acta medica Okayama.

[39]  Rita Kumar,et al.  Molecular Pathways of Protein Synthesis Inhibition during Brain Reperfusion: Implications for Neuronal Survival or Death , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[40]  J. Nevins,et al.  The E2F1–3 transcription factors are essential for cellular proliferation , 2001, Nature.

[41]  Y. Surh,et al.  Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. , 2001, Mutation research.

[42]  C. Proud,et al.  Regulation of elongation factor 2 kinase by p90RSK1 and p70 S6 kinase , 2001, The EMBO journal.

[43]  C. Proud,et al.  Interplay between insulin and nutrients in the regulation of translation factors. , 2001, Biochemical Society transactions.

[44]  G. Thomas,et al.  Ribosomal S6 kinase signaling and the control of translation. , 1999, Experimental cell research.

[45]  R. Rhoads.  Signal Transduction Pathways That Regulate Eukaryotic Protein Synthesis* , 1999, The Journal of Biological Chemistry.

[46]  S. Gammeltoft,et al.  Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction , 1999, Molecular and Cellular Endocrinology.

[47]  M. Lanotte,et al.  cAMP inhibits translation by inducing Ca2+/calmodulin‐independent elongation factor 2 kinase activity in IPC‐81 cells , 1999, FEBS letters.

[48]  R. Denton,et al.  Regulation of protein-synthesis elongation-factor-2 kinase by cAMP in adipocytes. , 1998, The Biochemical journal.

[49]  R. Schmid,et al.  Identification, culture, and characterization of pancreatic stellate cells in rats and humans. , 1998, Gastroenterology.

[50]  M. Korsten,et al.  Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture , 1998, Gut.

[51]  Robert A. Weinberg,et al.  Functional Inactivation of the Retinoblastoma Protein Requires Sequential Modification by at Least Two Distinct Cyclin-cdk Complexes , 1998, Molecular and Cellular Biology.

[52]  C. Proud,et al.  Molecular mechanisms for the control of translation by insulin. , 1997, The Biochemical journal.

[53]  Christine C. Hudson,et al.  Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. , 1997, Science.

[54]  G. Thomas,et al.  The modular phosphorylation and activation of p70s6k , 1997, FEBS letters.

[55]  M Wiedmann,et al.  Identification of a new class of protein kinases represented by eukaryotic elongation factor-2 kinase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[56]  Christopher G. Proud,et al.  Cloning and Expression of cDNA Encoding Protein Synthesis Elongation Factor-2 Kinase* , 1996, The Journal of Biological Chemistry.

[57]  A. Gingras,et al.  Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5'-cap function , 1994, Nature.

[58]  C. Proud.  Peptide-chain elongation in eukaryotes , 1994, Molecular Biology Reports.

[59]  C. Turck,et al.  Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit , 1993, Nature.

[60]  S. Martin,et al.  Protein or RNA synthesis inhibition induces apoptosis of mature human CD4+ T cell blasts. , 1993, Immunology letters.

[61]  James M. Roberts,et al.  Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle , 1992 .

[62]  T. Cotter,et al.  Induction of apoptosis (programmed cell death) in tumour cell lines by widely diverging stimuli. , 1990, Biochemical Society transactions.

[63]  A. Ryazanov,et al.  Phosphorylation of elongation factor 2 by EF-2 kinase affects rate of translation , 1988, Nature.

[64]  A. Nairn,et al.  Identification of calmodulin-dependent protein kinase III and its major Mr 100,000 substrate in mammalian tissues. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[65]  H. Marver,et al.  The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. , 1968, Proceedings of the National Academy of Sciences of the United States of America.

[66]  R. Potter,et al.  Carbon monoxide liberated from carbon monoxide-releasing molecule CORM-2 attenuates inflammation in the liver of septic mice. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[67]  C. Green,et al.  A carbon monoxide-releasing molecule (CORM-3) attenuates lipopolysaccharide- and interferon-gamma-induced inflammation in microglia. , 2006, Pharmacological reports : PR.

[68]  M. López-Lastra,et al.  Protein synthesis in eukaryotes: the growing biological relevance of cap-independent translation initiation. , 2005, Biological research.

[69]  P. Kleihues,et al.  Persistent inhibition of protein synthesis precedes delayed neuronal death in postischemic gerbil hippocampus , 2004, Acta Neuropathologica.

[70]  C. Proud,et al.  Role of mTOR signalling in the control of translation initiation and elongation by nutrients. , 2004, Current topics in microbiology and immunology.

[71]  A. Gingras,et al.  Control of translation by the target of rapamycin proteins. , 2001, Progress in molecular and subcellular biology.

[72]  S. Kimball.  Eukaryotic initiation factor eIF2. , 1999, The international journal of biochemistry & cell biology.

[73]  S. Kimball,et al.  Effect of amino acid deprivation on initiation of protein synthesis in rat hepatocytes. , 1989, The American journal of physiology.